JP2017502020A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502020A5
JP2017502020A5 JP2016540644A JP2016540644A JP2017502020A5 JP 2017502020 A5 JP2017502020 A5 JP 2017502020A5 JP 2016540644 A JP2016540644 A JP 2016540644A JP 2016540644 A JP2016540644 A JP 2016540644A JP 2017502020 A5 JP2017502020 A5 JP 2017502020A5
Authority
JP
Japan
Prior art keywords
group
alkyl
formula
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016540644A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502020A (ja
JP6491213B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/077937 external-priority patent/WO2015091463A1/en
Publication of JP2017502020A publication Critical patent/JP2017502020A/ja
Publication of JP2017502020A5 publication Critical patent/JP2017502020A5/ja
Application granted granted Critical
Publication of JP6491213B2 publication Critical patent/JP6491213B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016540644A 2013-12-18 2014-12-16 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体 Expired - Fee Related JP6491213B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361917623P 2013-12-18 2013-12-18
US61/917,623 2013-12-18
PCT/EP2014/077937 WO2015091463A1 (en) 2013-12-18 2014-12-16 Gamma-aminobutyric acid (gaba) analogues for the treatment of pain and other disorders

Publications (3)

Publication Number Publication Date
JP2017502020A JP2017502020A (ja) 2017-01-19
JP2017502020A5 true JP2017502020A5 (https=) 2018-02-01
JP6491213B2 JP6491213B2 (ja) 2019-03-27

Family

ID=52278595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540644A Expired - Fee Related JP6491213B2 (ja) 2013-12-18 2014-12-16 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体

Country Status (9)

Country Link
US (2) US9663479B2 (https=)
EP (1) EP3083572B1 (https=)
JP (1) JP6491213B2 (https=)
KR (1) KR102031334B1 (https=)
CN (2) CN105899495B (https=)
AU (1) AU2014364693B2 (https=)
CA (1) CA2932050C (https=)
RU (1) RU2679407C1 (https=)
WO (1) WO2015091463A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6491213B2 (ja) * 2013-12-18 2019-03-27 ノヴァッセイ エスエー 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体
CN107667097B (zh) * 2015-05-27 2021-02-12 诺瓦色生物公司 3-乙基双环[3.2.0]庚-3-烯-6-酮的对映体的分离
CN110818582B (zh) * 2019-11-20 2023-06-09 合肥拓锐生物科技有限公司 一种gaba类似物及其盐,及其合成方法、应用、药物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74380A (en) * 1993-04-01 1996-12-30 Univ Virginia 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives pharmaceutical compositions containing them, and process for producing former compounds
DE19508459A1 (de) * 1995-03-09 1996-09-12 Wacker Chemie Gmbh Verfahren zur Herstellung von Alkylsilanen mit sperrigen Alkylresten
CN1131855C (zh) * 1997-12-16 2003-12-24 沃尼尔·朗伯公司 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途
US6620829B2 (en) * 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
NZ545494A (en) * 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
BRPI0818193B8 (pt) * 2007-09-28 2021-05-25 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso de um composto
WO2010079668A1 (ja) 2009-01-08 2010-07-15 第一三共株式会社 オレフィン化合物
JP5557292B2 (ja) 2009-03-26 2014-07-23 第一三共株式会社 二環性γ−アミノ酸誘導体の製造方法
CN104755465A (zh) * 2012-08-24 2015-07-01 武田药品工业株式会社 杂环化合物
TWI635071B (zh) * 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ-胺基酸衍生物及其製造方法
JP6491213B2 (ja) * 2013-12-18 2019-03-27 ノヴァッセイ エスエー 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体

Similar Documents

Publication Publication Date Title
PH12018500940A1 (en) N-[2-(1 -benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1 -carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases
MX2013010044A (es) Nuevas composiciones para tratar transtornos neurologicos.
JP2017502020A5 (https=)
JP2015536307A5 (https=)
JP2015511958A5 (https=)
CO2019006785A2 (es) Inhibidores biciclo[1.1.1]pentano de la cinasa de cremallera de leucina dual (dlk) para el tratamiento de enfermedades
JP2016508142A5 (https=)
HRP20251221T1 (hr) Neuroaktivni steroidi i postupci za njihovu uporabu
NZ725262A (en) Cyclopropanamine compound and use thereof
PH12016502231B1 (en) Indolin-2-one or pyrrolo-pyridin-2-one derivatives
JP2014505690A5 (https=)
HRP20211272T1 (hr) 24-hidroksisteroli supstituirani na poziciji 11 za uporabu u liječenju stanja povezanih sa nmda
JP2015523406A5 (https=)
MX367023B (es) Composicion que comprende torasemida y baclofeno para tratar trastornos neurologicos.
JP2009530237A5 (https=)
JP2018508592A5 (https=)
IN2015DN00957A (https=)
MX2016008842A (es) Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos.
SMT201700142T1 (it) SALE DI CAMSILATO DI (1r, 1’R, 4R)-4-METOSSI-5’’-METIL-6’-[5-(PROP-1-IN-1-IL)PIRIDIN-3-IL]-3’H-DISPIRO[CICLOESANO-1,2’-INDEN-1’2’-IMIDAZOLO]-4’’-AMMINA E SUE FORME CRISTALLINE PER IL TRATTAMENTO DI PATOLOGIE A[BETA]-CORRELATE COME PER ESEMPIO LA MALATTIA DI ALZHEIMER
MX2019002444A (es) Inhibidores de cinasa de cremallera de leucina dual (dlk) para el tratamiento de enfermedades.
JP2017520540A5 (https=)
EA201791367A1 (ru) Соединения 2,3,4,5-тетрагидропиридин-6-амин и 3,4-дигидро-2h-пиррол-5-амин - ингибиторы бета-секретазы
HRP20110196T1 (hr) 3,5-disupstituirani fenil-piperidini kao modulatori dopamina neurotransmisije
JP2014518552A5 (https=)
JP2017522370A5 (https=)